Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Revere Biosensors LLC is currently navigating 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution is overseen by 1 distinct examiner, which provides a single point of contact for the company's active patent application. Furthermore, the portfolio is associated with 1 distinct art unit, indicating that the technology is being reviewed within a specific administrative group at the USPTO. This concentration in the art unit allows for a specialized understanding of the relevant examination standards.
The busiest examiner for the portfolio is CROW, ROBERT THOMAS, who is managing 1 busiest examiner pending office action. Because there is only 1 distinct examiner for the entire portfolio, this individual is responsible for all current active prosecution. The 1 pending office action represents the total active workload for the company at this time. This focused prosecution environment allows the company to concentrate its resources on a single set of examiner requirements. By addressing 1 pending office action with 1 distinct examiner and 1 distinct art unit, the company can maintain a very specific legal strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CROW, ROBERT THOMAS | 1 | 41.7% | +32.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18336201 | SYSTEMS AND METHODS FOR IDENTIFYING AND DISTINGUISHING GENETIC SAMPLES | CROW, ROBERT THOMAS | 14d |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18336201 | SYSTEMS AND METHODS FOR IDENTIFYING AND DISTINGUISHING GENETIC SAMPLES | CROW, ROBERT THOMAS | 1683 | §103DP | Final Rejection | 14d | Pending | Jun 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial